Human models of aromatase deficiency

Journal of Steroid Biochemistry and Molecular Biology

Volumn 109, Issue 3-5, 2008, Pages 212-218

  Zirilli, Lucia ^a   Rochira, Vincenzo ^a   Diazzi, Chiara ^a   Caffagni, Giovanni ^a   Carani, Cesare ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Aromatase gene; Bone maturation; Bone mineral density; Estradiol testosterone ratio; Estrogens deficiency

Indexed keywords

AROMATASE; ESTRADIOL;

ADULT; AMENORRHEA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; BREAST DEVELOPMENT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ESTROGEN DEFICIENCY; FEMALE; GENE MUTATION; HUMAN; HYPERANDROGENISM; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; OSTEOPENIA; OSTEOPOROSIS; PATHOPHYSIOLOGY; PHENOTYPE; VIRILIZATION;

ADOLESCENT; ADULT; ANIMALS; AROMATASE; BONE DENSITY; CHILD; CHILD, PRESCHOOL; ESTROGENS; FEMALE; GLYCOLIPIDS; HUMANS; INFANT, NEWBORN; METABOLIC DISEASES; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; MUTATION;

EID: 44149093534     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2008.03.026     Document Type: Article

References (55)

1. Deroo B.J., and Korach K.S. Estrogen receptors and human disease. J. Clin. Invest. 116 (2006) 561-570
2. Rochira V., Granata A.R., Madeo B., Zirilli L., Rossi G., and Carani C. Estrogens in males: what have we learned in the last 10 years?. AJA 7 (2005) 3-20
3. Faustini-Fustini M., Rochira V., and Carani C. Oestrogen deficiency in men: where are we today?. Europ. J. Endocrinol. 140 (1999) 111-129
4. MacDonald P.C., Madden J.D., Brenner P.F., Wilson J.D., and Siiteri P.K. Origin of estrogen in normal men and in women with testicular feminization. J. Clin. Endocrinol. Metab. 49 (1979) 905-916
5. Simpson E.R., Mahendroo M.S., Means G.D., Kilgore M.W., Hinshelwood M.M., Graham-Lorence S., Amarneh B., Ito Y., Fisher R., Michael M.D., Mendelson C.R., and Bulun S.E. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocrine Rev. 15 (1994) 342-355
6. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., et al. The nuclear receptor superfamily: the second decade. Cell 83 (1995) 835-839
7. Enmark E., and Gustafsson J.A. Oestrogen receptors-an overview. J. Internal Med. 246 (1999) 133-138
8. Levin E.R. Cellular functions of the plasma membrane estrogen receptor. Trends Endocrinol. Metab. 10 (1999) 374-377
9. Gruber C.J., Tschugguel W., Schneeberger C., and Huber J.C. Production and actions of estrogens. N. Engl. J. Med. 346 5 (2002) 340-352
10. Couse J.F., and Korach K.S. Estrogen receptor null mice: what have we learned and where will they lead us?. Endocrine Rev. 20 (1999) 358-417
11. George F.W., and Wilson J.D. Sex Determination and Differentiation. The Physiology of Reproduction (1988), Knobil & Neill Raven Press
12. Shozu M., Akasofu K., Harada T., and Kubota Y. A new cause of female pseudohermaphroditism: placental aromatase deficiency. J. Clin. Endocrinol. Metab. 72 3 (1991) 560-566
13. Harada N., Ogawa H., Shozu M., and Yamada K. Genetic studies to characterize the origin of the mutation in placental aromatase deficiency. Am. J. Hum. Genet. 51 (1992) 666-672
14. Conte F.A., Grumbach M.M., Ito Y., Fisher C.R., and Simpson E.R. A syndrome of female pseudohermaphroditism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J. Clin. Endocrinol. Metab. 78 (1994) 1287-1292
15. Ito Y., Fisher C.R., Conte F.A., Grumbach M.M., and Simpson E.R. Molecular basis of the aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 11673-11677
16. Morishima A., Grumbach M.M., Simpson E.R., Fisher C., and Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J. Clin. Endocrinol. Metab. 80 (1995) 3689-3698
17. Smith E.P., Boyd J., Frank G.R., Takahashi H., Cohen R.M., Specker B., Williams T.C., Lubahn D.B., and Korach K.S. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N. Engl. J. Med. 331 (1994) 1056-1061
18. Mullis P.E., Yoshimura N., Kuhlmann B., Lippuner K., Jaeger P., and Harada H. Aromatase deficiency in a female who is compound heterozygote for new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood. J. Clin. Endocrinol. Metab. 82 (1997) 1739-1745
19. Portrait-Doyen S., Forest M.G., Nicolino M., Morel Y., and Chatelain P.C. Female pseudohermaphroditism resulting from aromatase (P40arom) deficiency associated with a novel mutation R457X) in the CYP19 gene. Horm. Res. 46 Suppl. 2 (1996) 14
20. Ludwig M., Beck A., Wickert L., Bolkenius U., Tittel B., Hinkel K., and Bidlingmaier F. Female pseudohermaphroditism associated with a novel homozygous G-to-A (V370-to-M) substitution in the P-450 aromatase gene. J. Pediatr. Endocrinol. Metab. 11 (1998) 657-664
21. Belgorosky A., Pepe C., Marino R., Guercio C., Saraco N., Vaiani E., and Rivarola M.A. Hypothalamic-pituitary-ovarian axis during infancy, early and late prepuberty in an aromatase-deficient girl who is a compound heterozygote for two new point mutations of the CYP19 gene. J. Clin. Endocrinol. Metab. 88 (2003) 5127-5131
22. Lin L., Eran O., Raza J., Burren C.P., Creighton S.M., Auchus R.J., Dattani M.T., and Acherman J.C. Variable phenotypes associated with aromatase (CYP19) insufficiency in humans. J. Clin. Endocrinol. Metab. 92 3 (2007) 982-990
23. Carani C., Qin K., Simoni M., Faustini-Fustini M., Serpente S., Boyd J., Korach K.S., and Simpson E.R. Effect of testosterone and estradiol in a man with aromatase deficiency. N. Engl. J. Med. 337 (1997) 91-95
24. Deladoey J., Fluck C., Bex M., Yoshimura N., Harada N., and Mullis P.E. Aromatase deficiency caused by a novel P450arom gene mutation: impact of absent estrogen production on serum gonadotropin concentration in a boy. J. Clin. Endocrinol. Metab. 84 11 (1999) 4050-4054
25. Bouillon R., Bex M., Vanderschueren D., and Boonen S. Estrogen are essential for male pubertal periostal bone expansion. J. Clin. Endocrinol. Metab. 89 (2004) 6025-6029
26. Herrmann B.L., Saller B., Janssen O.E., Gocke P., Bockisch A., Sperling H., Mann K., and Broecker M. Impact of Estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene. J. Clin. Endocrinol. Metab. 87 (2002) 5476-5484
27. M. Pura, H. Mittre, S. Carreau, M.L. Kottler, Clinical findings in an adult man with a novel mutation in the aromatase gene. Program of the 85th Annual Meeting of the Endocrine Society, Abstract Book Philadelphia, PA (2003) P-467: 243 (abstract).
28. Maffei L., Murata Y., Rochira V., Tubert G., Aranda C., Vasquez M., Clyne C.D., Davis S., Simpson E.R., and Carani C. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J. Clin. Endocrinol. Metab. 89 (2004) 61-70
29. Maffei L., Rochira V., R: Simpson E., Simone M.L., Arnda C., Fabre B., Stivel M., Luberto A., Balestrieri A., Pignatti E., Antunez P., and Carani C. A novel compound heterozygous mutation of the aromatase gene in an adult man. Program of the 88th Annual Meeting of the Endocrine Society, Abstract Book Boston (2006) P1-857
30. Rochira V., Balestrieri A., Madeo B., Spaggiari A., and Carani C. Congenital estrogen deficiency in men: a new syndrome with different phenotypes; clinical and therapeutic implications in men. Mol. Cell. Endocrinol. 193 (2002) 19-28
31. Jones M.E., Boon W.C., Proietto J., and Simpson E.R. Of mice and men: the evolving phenotype of aromatase deficiency. Trends Endocrinol. Metab. 17 2 (2006) 55-64
32. Grumbach M.M., and Auchus R.J. Estrogen: consequences and implications of human mutations in synthesis and action. J. Clin. Endocrinol. Metab. 84 (1999) 4677-4694
33. Balestrieri A., Faustini-Fustini M., Rochira V., and Carani C. Clinical implications and management of oestrogen deficiency in the male. Clin. Endocrinol. 54 4 (2001) 431-432
34. Lee P.A., and Witchel S.F. The influence of estrogen on growth. Curr. Opin. Pediatr. 9 (1997) 431-436
35. Klein K.O., Martha Jr. P.M., Blizzard R.M., Herbst T., and Rogol A.D. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. II. Estrogen levels as determined by an ultrasensitive bioassay. J. Clin. Endocrinol. Metab. 81 9 (1996) 3203-3207
36. Cutler Jr. G.B. The role of estrogen in bone growth and maturation during childhood and adolescence. J. Steroid Biochem. Mol. Biol. 61 (1997) 141-144
37. Rochira V., Balestrieri A., Faustini-Fustini M., and Carani C. Role of estrogen on bone in the human male: insights from the natural models of congenital estrogen deficiency. Mol. Cell. Endocrinol. 178 1-2 (2001) 215-220
38. Bilezikian J.P., Morishima A., Bell J., and Grumbach M.M. Increased bone mass as a result of estrogen therapy in a man with AD. N. Engl. J. Med. 339 (1998) 599-603
39. Zachmann M., Prader A., Sabel E.H., Crigler J.F., Ritzen M.R., Atares M., and Ferrandez A.F. Pubertal growth in patients with androgen insensitivity: indirect evidence for the importance of estrogens in pubertal growth girls. J. Pediatr. 108 (1986) 694-697
40. Rochira V., Balestrieri A., Madeo B., Birilli L., Granata A.R.M., and Carani C. Osteoporosis and male age-related hypogonadism: role of sex steroids on bone patho(physiology). Eur. J. Endocrinol. 154 (2006) 175-185
41. Kohsla S., 3rd Melton L.J., Atkinson E.J., Klee G.G., and Riggs B.L. Relationship of serum sex steroid level and bone turn-over markers with bon mineral density in men and women: a key role for bioavailable estrogen. J. Clin. Endocrinol. Metab. 83 (1998) 2266-2274
42. Barret-Connor E., Mueller J.E., von Muhlen D.G., Laughlin G.A., Schneider D.L., and Sartoris D.J. Low levels of estradiol are associated with vertebral fractures in older men, but not in women: the Rancho Bernardo Study. J. Clin. Endocrinol. Metab. 85 (2000) 219-223
43. Rochira V., Faustini-Fustini M., Balestrieri A., and Carani C. Estrogen replacement therapy in a man with congenital aromatase deficiency: effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters J. Clin. Endocrinol. Metab. 85 (2000) 1841-1845
44. Seeman E. Sexual dimorphism in skeletal size, density, and strength. J. Clin. Endocrinol. Metab. 86 10 (2001) 4576-4584
45. Vottero A., Rochira V., Capelletti M., Viani I., Zirilli L., Neri T.M., Carani C., Bernasconi S., and Ghizzoni L. Aromatase is differentially expressed in peripheral blood leukocytes from children, and adult female and male subjects. Eur. J. Endocrinol. 154 3 (2006) 425-431
46. Finkelstein J.S., Klibanski A., and Neer R.M. A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty. J. Clin. Endocrinol. Metab. 81 (1996) 1152-1155
47. Jones M.E.E., Thorburn A.W., Britt K.L., Hewitt K.N., Wreford N.G., Proietto J., Oz O.K., Leury B.J., Robertson K.M., Yao S., and Simpson E.R. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. PNAS 97 (2000) 12735-12740
48. Takeda K., Toda K., Saibara T., Nakagawa M., Saika K., Onishi T., Sugiura T., and Shizuta Y. Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J. Endocrinol. 176 (2003) 237-246
49. Herrmann B.L., Janssen O.E., Hahn S., Broeker-Preuss M., and Mann K. Effects of estrogen replacement therapy on bone and glucose metabolism in a male with congenital aromatase deficiency. Horm. Met. Res. 37 (2005) 178-183
50. Singh A.B., Hsia S., Alaupovic P., Sinha-Hikim I., Woodhouse L., Buchanan T.A., Shen R., Bross R., Berman N., and Bhasin S. The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins and C-reactive protein in healthy young men. J. Clin. Endocrinol. Metab. 87 (2002) 136-143
51. Marchesini G., Brizi M., Morselli-Labate A.M., Bianchi G., Bugianesi E., McCullogh A.J., Forlani G., and Melchionda N. Association of nonalcoholic fatty liver disease with insulin resistance. Am. J. Med. 107 (1999) 450-455
52. Nemoto Y., Toda K., Ono M., Fujikawa-Adachi K., Saibara T., Onishi S., Enzan H., Okada T., and Shizuta Y. Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice. J. Clin. Invest. 105 (2000) 1819-1825
53. Asscheman H., Gooren L.J., Megens J.A., Nauta J., Kloosterboer H.J., and Eikelboom F. Serum testosterone level is the major determinant of the male-female differences in serum levels of high-density lipoprotein (HDL) cholesterol and HDL2 cholesterol. Metabolism 43 (1994) 935-939
54. von Eckardstein A., Kleisch S., Nieschlag E., Chirazi A., Assmann G., and Behre H.M. Suppression of endogenous testosterone in young men increases serum levels of high density lipoprotein subclass lipoprotein A-I and lipoprotein(a). J. Clin. Endocrinol. Metab. 82 (1997) 3367-3372
55. Sudhir K., Chou T.M., Messima L.M., Hutchinson S.J., Korach K.S., Chatterjee K., and Rubanyi G.M. Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene. Lancet 349 (1997) 1146-1147